Ajinomoto Group Ventures is the corporate venture capital arm of Ajinomoto Co., Inc., a $10B revenue technology leader in amino science. It invests in global transformative startups across healthcare, biotech & life sciences, food & agriculture, and climate & energy, leveraging Ajinomoto Group resources to drive impact.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Their most common stage is series-a (58% of deals). Average disclosed round size is $48.6M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRestore Vision Inc. | Series A | — | Jan 2026 |
 Mixx Technologies | Series A | $33M | Dec 2025 |
 Somite | Series A | $47M | May 2025 |
| Mixx Technologies | Series A | $33M | Jan 2025 |
| SSafire Technology Group, Inc. | Unknown | — | Sep 2024 |
| SSafire Technology Group, Inc. | Series A | $8M | Jan 2024 |
 Ascend Advanced Therapies | Series A | $130M | Jan 2023 |
| TTsubame BHB Co.,Ltd. | Series C | — | Jul 2022 |
| TTsubame BHB Co.,Ltd. | Unknown | — | Jan 2022 |
 MycoTechnology | Series B | $42M | Oct 2017 |
 Cellular Intelligence | Series A | $47M | — |
| RRestore Vision Inc. | Series B | — | — |
Top Co-Investors
Astellas Venture Management3 shared
Harpoon Ventures2 shared
Chan Zuckerberg Initiative2 shared
Fusion Fund2 shared
SciFi VC2 shared
Khosla Ventures2 shared
TechAviv2 shared
Systemiq Capital2 shared
TDK Ventures2 shared
ICM HPQC Fund2 shared
ANRI2 shared
JIC Venture Growth Investments2 shared
Development Bank of Japan Inc.2 shared
Pitango HealthTech1 shared
Hoxton Ventures1 shared
AMD Ventures1 shared
Pitango VC1 shared
Lerer Hippeau1 shared
CapitalG1 shared
SMBC Venture Capital1 shared
Last updated: 7 October 2026